Claim: the mRNA vaccines cause cardiovascular side effects
Thai peer reviewed study finds cardiovascular side effects in 29% of adolescent participants; whilst 94.6% of vaccinated patients show blood abnormalities following vaccination.
There is now a plethora of evidence of cardiovascular effects of mRNA vaccination. A peer reviewed study from Thailand finds cardiovascular side effects in 29% of adolescent participants; whilst 94.6% of vaccinated patients show blood abnormalities following vaccination in a study using dark field microscopic analysis.
Also, in a recent peer reviewed study, increased emergency cardiovascular events have been noticed in Israel in the under 40 population, during the vaccine rollout. Unsurprisingly, this conclusion is being challenged - of course these challenges wouldn’t have anything to do with the vast amount of money at stake in these vaccines, would they?
29.24% of adolescent patients have cardiovascular effects in study from Thailand.
A study from Thailand on a small group of around 300 school children found cardiovascular side effects in 29.24% of adolescent patients who took the Pfizer vaccine, ranging from tachycardia, palpitation, and myopericarditis. The assertion of the study is that the myocarditis resolved after 14 days should possibly be taken with a grain of salt, in that there was no followup after 14 days.
This study focuses on cardiovascular effects, particularly myocarditis and pericarditis events, after BNT162b2 mRNA COVID-19 vaccine injection in Thai adolescents. This prospective cohort study enrolled students from two schools aged 13–18 years who received the second dose of the BNT162b2 mRNA COVID-19 vaccine. Data including demographics, symptoms, vital signs, ECG, echocardiography and cardiac enzymes were collected at baseline, Day 3, Day 7, and Day 14 (optional) using case record forms.We enrolled 314 participants; of these, 13 participants were lost to follow up, leaving 301 participants for analysis. The most common cardiovascular effects were tachycardia (7.64%), shortness of breath (6.64%), palpitation (4.32%), chest pain (4.32%), and hypertension (3.99%). Seven participants (2.33%) exhibited at least one elevated cardiac biomarker or positive lab assessments. Cardiovascular effects were found in 29.24% of patients, ranging from tachycardia, palpitation, and myopericarditis. Myopericarditis was confirmed in one patient after vaccination. Two patients had suspected pericarditis and four patients had suspected subclinical myocarditis. Conclusion: Cardiovascular effects in adolescents after BNT162b2 mRNA COVID-19 vaccination included tachycardia, palpitation, and myocarditis. The clinical presentation of myopericarditis after vaccination was usually mild, with all cases fully recovering within 14 days. Hence, adolescents receiving mRNA vaccines should be monitored for side effects. Clinical Trial Registration: NCT05288231
Cardiologists are seeing many more cases of heart inflammation since the rollout of the vaccines, and the likelihood of myocarditis is greatly increased by vaccination for those under 40.
Dark field microscopic analysis shows blood abnormalities in 94.6% of patients following vaccination.
Also, in a recent peer reviewed study, dark field microscopic analysis of 1006 vaccinated patients immediately following vaccination showed blood abnormalities in 946 of them, or 94.6%.
Israeli Study
The Israeli study examines the records of Emergency Services and finds an increased callout rate for cardiovascular events in the 16-39 age group during the vaccination rollout. This very concerning outcome calls into question the efficacy of self-reporting surveillance systems in getting to the actual facts.
The significant increases in CA calls and ACS calls among the 16–39 age population during the COVID-19 vaccination rollout highlights the value of additional data sources, such as those from EMS systems, that can supplement self-reporting surveillance systems in identifying concerning public health trends. Moreover, it underscores the need for the thorough investigation of the apparent association between COVID-19 vaccine administration and adverse cardiovascular outcomes among young adults. Israel and other countries should immediately collect the data necessary to determine whether such association indeed exists, including thorough investigation of individual CA and ACS cases in young adults, and their potential connection to the vaccine or other factors. This would be critical to better understanding the risk-benefits of the vaccine and to inform related public policy and prevent potentially avoidable patient harm. In the interim, it is vital that following vaccination, patients should be instructed to seek appropriate emergency care if they are experiencing symptoms potentially associated with myocarditis, such as chest discomfort and shortness of breath, as well as consider avoiding strenuous physical activity following the vaccination that may induce severe adverse cardiac events.
When considering the objections to this article, which takes data from a very objective source, we should remember that the peer review process is broken, because of the influence of Big Pharma.
References
Sun, C.L.F., Jaffe, E. & Levi, R. Increased emergency cardiovascular events among under-40 population in Israel during vaccine rollout and third COVID-19 wave. Sci Rep 12, 6978 (2022). https://doi.org/10.1038/s41598-022-10928-z
https://www.nature.com/articles/s41598-022-10928-z#citeas
Patone, M., Mei, X.W., Handunnetthi, L. et al. Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nat Med 28, 410–422 (2022). https://doi.org/10.1038/s41591-021-01630-0
https://www.nature.com/articles/s41591-021-01630-0
Mansanguan, S.; Charunwatthana, P.; Piyaphanee, W.; Dechkhajorn, W.; Poolcharoen, A.; Mansanguan, C. Cardiovascular Manifestation of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents. Trop. Med. Infect. Dis. 2022, 7, 196. https://doi.org/10.3390/tropicalmed7080196
https://www.mdpi.com/2414-6366/7/8/196
Franco Giovannini, MD1, Riccardo Benzi Cipelli, MD,DDS2, and Gianpaolo Pisano, MD,OHNS3 Dark -Field MicroscopicAnalysis on the Blood of 1,006 Symptomatic PersonsAfter Anti-COVIDmRNA Injections from Pfizer/BioNtech or Moderna IJVTPR 2(2), August 12, 2022 Pages 385-444
https://ijvtpr.com/index.php/IJVTPR/article/view/47
Jureidini J, McHenry L B. The illusion of evidence based medicine BMJ 2022; 376 :o702 doi:10.1136/bmj.o702
https://www.bmj.com/content/376/bmj.o702
Change log
6:20am Added the Israeli study